Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INTERVIEW: Admedus cardiovascular scaffold could cut repeat surgeries

This article was originally published in Clinica

Executive Summary

Xenografts of animal tissue (usually from cows or pigs) are commonly used for patients with structural heart problems, but have several drawbacks. The main issue is that the tissue calcifies so need to be replaced regularly. In the case of children with congenital heart disease (CHD), this means several repeat operations at a young age, which is stressful and can cause other health problems itself.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel